Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.

Huisingh C, McGwin G.

Br J Ophthalmol. 2014 Apr;98(4):570-1. doi: 10.1136/bjophthalmol-2013-304805. Epub 2014 Jan 17. No abstract available.

PMID:
24443393
2.

Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.

Modi RR, Behera UC, Sureka SP.

Br J Ophthalmol. 2014 Jun;98(6):846-7. doi: 10.1136/bjophthalmol-2014-305025. Epub 2014 Feb 26. No abstract available.

PMID:
24574438
3.

Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.

Chen SN, Lian I.

Br J Ophthalmol. 2014 Jul;98(7):997. doi: 10.1136/bjophthalmol-2014-305148. Epub 2014 Mar 19. No abstract available.

PMID:
24648418
4.

Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.

Chen SN, Chen YC, Lian I.

Br J Ophthalmol. 2014 Jan;98(1):110-4. doi: 10.1136/bjophthalmol-2013-303945. Epub 2013 Oct 29.

PMID:
24169652
5.

Authors' response.

Chen SN, Lian I.

Br J Ophthalmol. 2014 Apr;98(4):572. doi: 10.1136/bjophthalmol-2013-304862. Epub 2014 Jan 31. No abstract available.

PMID:
24489376
6.

Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.

Tsai DC, Huang CC, Chen SJ, Chou P, Chung CM, Chan WL, Huang PH, Lin SJ, Chen JW, Leu HB.

Acta Ophthalmol. 2013 Nov;91(7):666-71. doi: 10.1111/j.1755-3768.2012.02528.x. Epub 2012 Sep 23.

7.

Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study.

Tsai DC, Huang CC, Chen SJ, Chou P, Chung CM, Chan WL, Huang PH, Chen TJ, Lin SJ, Chen JW, Leu HB.

Br J Ophthalmol. 2012 Dec;96(12):1484-8. doi: 10.1136/bjophthalmol-2012-301810. Epub 2012 Sep 13.

PMID:
22976583
8.

Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy.

Casella AM, Berbel RF, Bressanim GL, Malaguido MR, Cardillo JA.

Clinics (Sao Paulo). 2012 Sep;67(9):1047-52.

9.

Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.

Tsai DC, Chen SJ, Huang CC, Chou P, Chung CM, Huang PH, Lin SJ, Chen JW, Chen TJ, Leu HB, Chan WL.

PLoS One. 2013 Jun 24;8(6):e66858. doi: 10.1371/journal.pone.0066858. Print 2013.

10.

Incidence and natural course of symptomatic central serous chorioretinopathy in pregnant women in a maternity hospital in Kuwait.

Said-Ahmed K, Moustafa G, Fawzy M.

Middle East Afr J Ophthalmol. 2012 Jul-Sep;19(3):273-6. doi: 10.4103/0974-9233.97920.

11.

[Serous central chorioretinopathy and tadalafil: a case report].

Nadeau S, Nguyen F, Guigou S.

J Fr Ophtalmol. 2012 Feb;35(2):121.e1-5. doi: 10.1016/j.jfo.2011.02.016. Epub 2011 Jun 15. French.

12.

[Irvine Gass syndrome and central serous chorioretinopathy, pure coincidence or non fortuitous association? Report of three cases].

Boulanger G, Weber M.

J Fr Ophtalmol. 2009 Oct;32(8):566-71. doi: 10.1016/j.jfo.2009.05.003. Epub 2009 Aug 4. French.

13.

Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.

Imamura Y, Fujiwara T, Margolis R, Spaide RF.

Retina. 2009 Nov-Dec;29(10):1469-73. doi: 10.1097/IAE.0b013e3181be0a83.

PMID:
19898183
14.

Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy.

Behnia M, Khabazkhoob M, Aliakbari S, Abadi AE, Hashemi H, Pourvahidi P.

Retina. 2013 Feb;33(2):324-8. doi: 10.1097/IAE.0b013e3182670fa3.

PMID:
23314231
16.

Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.

Maruko I, Iida T, Ojima A, Sekiryu T.

Retina. 2011 Apr;31(4):759-65. doi: 10.1097/IAE.0b013e3181fbce8e.

PMID:
21052035
17.

[Recurrent and chronic central serous chorioretinopathy. Retina thickness evaluation one month after intravitreal bevacizumab injection].

Gregori-Gisbert I, Aguirre-Balsalobre F, García-Sánchez J, León-Salvatierra G, Mengual-Verdú E, Hueso-Abancéns JR.

Arch Soc Esp Oftalmol. 2011 Dec;86(12):407-11. doi: 10.1016/j.oftal.2011.05.021. Epub 2011 Oct 11. Spanish.

PMID:
22117740
18.

Central serous chorioretinopathy after surgical repair of a blowout fracture.

Chang M, Baek S, Lee TS.

J Craniofac Surg. 2012 Nov;23(6):1923-4. doi: 10.1097/SCS.0b013e318271026c.

PMID:
23172445
19.

Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.

Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H.

Curr Eye Res. 2010 Feb;35(2):91-8. doi: 10.3109/02713680903428306.

PMID:
20136418
20.

Intravitreal bevacizumab injection for central serous chorioretinopathy.

Lim SJ, Roh MI, Kwon OW.

Retina. 2010 Jan;30(1):100-6. doi: 10.1097/IAE.0b013e3181bcf0b4.

PMID:
20010322

Supplemental Content

Support Center